These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Synthesis and molecular modeling of a lisinopril-tryptophan analogue inhibitor of angiotensin I-converting enzyme. Nchinda AT; Chibale K; Redelinghuys P; Sturrock ED Bioorg Med Chem Lett; 2006 Sep; 16(17):4616-9. PubMed ID: 16784843 [TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design. Corradi HR; Schwager SL; Nchinda AT; Sturrock ED; Acharya KR J Mol Biol; 2006 Mar; 357(3):964-74. PubMed ID: 16476442 [TBL] [Abstract][Full Text] [Related]
9. Simulated interactions between angiotensin-converting enzyme and substrate gonadotropin-releasing hormone: novel insights into domain selectivity. Papakyriakou A; Spyroulias GA; Sturrock ED; Manessi-Zoupa E; Cordopatis P Biochemistry; 2007 Jul; 46(30):8753-65. PubMed ID: 17605472 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel keto-ACE analogues as domain-selective angiotensin I-converting enzyme inhibitors. Nchinda AT; Chibale K; Redelinghuys P; Sturrock ED Bioorg Med Chem Lett; 2006 Sep; 16(17):4612-5. PubMed ID: 16784850 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and enzymatic evaluation of novel partially fluorinated thiol dual ACE/NEP inhibitors. Olimpieri F; Tambaro S; Fustero S; Lazzari P; Sanchez-Roselló M; Pani L; Volonterio A; Zanda M Bioorg Med Chem Lett; 2009 Aug; 19(16):4715-9. PubMed ID: 19596577 [TBL] [Abstract][Full Text] [Related]
12. The molecular basis for the selection of captopril cis and trans conformations by angiotensin I converting enzyme. Tzakos AG; Naqvi N; Comporozos K; Pierattelli R; Theodorou V; Husain A; Gerothanassis IP Bioorg Med Chem Lett; 2006 Oct; 16(19):5084-7. PubMed ID: 16889963 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin I-converting enzyme inhibitor peptides derived from the endostatin-containing NC1 fragment of human collagen XVIII. Farias SL; Sabatini RA; Sampaio TC; Hirata IY; Cezari MH; Juliano MA; Sturrock ED; Carmona AK; Juliano L Biol Chem; 2006 May; 387(5):611-6. PubMed ID: 16740133 [TBL] [Abstract][Full Text] [Related]
15. Thermodynamic determination of the binding constants of angiotensin-converting enzyme inhibitors by a displacement method. Andújar-Sánchez M; Jara-Pérez V; Cámara-Artigas A FEBS Lett; 2007 Jul; 581(18):3449-54. PubMed ID: 17618628 [TBL] [Abstract][Full Text] [Related]
16. Rational design of angiotensin-I-converting enzyme inhibitory peptides by integrating in silico modeling and an in vitro assay. Jing T; Feng J; Li D; Liu J; He G ChemMedChem; 2013 Jul; 8(7):1057-66. PubMed ID: 23740817 [TBL] [Abstract][Full Text] [Related]
17. Structure of angiotensin I-converting enzyme. Sturrock ED; Natesh R; van Rooyen JM; Acharya KR Cell Mol Life Sci; 2004 Nov; 61(21):2677-86. PubMed ID: 15549168 [TBL] [Abstract][Full Text] [Related]
18. Novel whey-derived peptides with inhibitory effect against angiotensin-converting enzyme: in vitro effect and stability to gastrointestinal enzymes. Tavares T; Contreras Mdel M; Amorim M; Pintado M; Recio I; Malcata FX Peptides; 2011 May; 32(5):1013-9. PubMed ID: 21335046 [TBL] [Abstract][Full Text] [Related]
19. Direct spectrophotometric measurement of angiotensin I-converting enzyme inhibitory activity for screening bioactive peptides. Li GH; Liu H; Shi YH; Le GW J Pharm Biomed Anal; 2005 Feb; 37(2):219-24. PubMed ID: 15708660 [TBL] [Abstract][Full Text] [Related]